Literature DB >> 16241980

Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study.

L Vignatelli1, R Rinaldi, M Galeotti, P de Carolis, R D'Alessandro.   

Abstract

We performed a 2-year population-based study on status epilepticus (SE) in adults in the rural area of Lugo di Romagna, northern Italy, to verify whether an area of low-level urbanization has a lower risk of occurrence of SE (as recently suggested), different clinical features and short-term prognosis than areas of high-level urbanization. We found crude and age- and sex-adjusted annual incidence rates of SE of 16.5/100 000 and 11.6/100 000, respectively. In patients under 60 years crude incidence was 2.9/100 000 and in the elderly (>/=60 years) 38.6/100 000. Acute symptomatic SE accounted for 30% and a cerebrovascular pathology was the most frequently associated etiologic condition (60%). A history of seizures was reported in 41% of patients. The first therapeutic intervention was mainly benzodiazepines (lorazepam 46%; diazepam 33%). The 30-day case fatality was 7%. We observed that the adult population of an area with a low level of urbanization has the same risk for SE, clinical features and short-term prognosis as European urban areas. The only contrasting result is the 30-day case fatality of 7% against the 39% found in the other Italian study (Bologna), despite the similarity of the SE features in these two areas of the same region. We infer that the short-term prognosis of SE could also be considerably influenced by differences in health service organization (and hence management) possibly due to different levels of urbanization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16241980     DOI: 10.1111/j.1468-1331.2005.01073.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  17 in total

1.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

Review 2.  [Refractory status epilepticus: diagnosis, therapy, course, and prognosis].

Authors:  F Bösebeck; G Möddel; K Anneken; M Fischera; S Evers; E B Ringelstein; C Kellinghaus
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

3.  Status epilepticus of inflammatory etiology: a cohort study.

Authors:  Marianna Spatola; Jan Novy; Renaud Du Pasquier; Josep Dalmau; Andrea O Rossetti
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

4.  Epidemiology, management and outcome of status epilepticus in adults: single-center Italian survey.

Authors:  Carlotta Mutti; Angelo Sansonetti; Giampiero Monti; Claudia Vener; Irene Florindo; Anna Elisabetta Vaudano; Irene Trippi; Giorgia Bernabè; Liborio Parrino; Lucia Zinno
Journal:  Neurol Sci       Date:  2021-09-06       Impact factor: 3.307

5.  Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study.

Authors:  Vincent Alvarez; Jong Woo Lee; M Brandon Westover; Frank W Drislane; Jan Novy; Mohamed Faouzi; Nicola A Marchi; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

6.  Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts.

Authors:  Luca Vignatelli; Rita Rinaldi; Elisa Baldin; Paolo Tinuper; Roberto Michelucci; Massimo Galeotti; Piero de Carolis; Roberto D'Alessandro
Journal:  J Neurol       Date:  2008-01-23       Impact factor: 4.849

7.  Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy.

Authors:  Andrea O Rossetti; Giancarlo Logroscino; Tracey A Milligan; Costas Michaelides; Christiane Ruffieux; Edward B Bromfield
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

8.  Intravenous levetiracetam as treatment for status epilepticus.

Authors:  Sascha Berning; Frank Boesebeck; Andreas van Baalen; Christoph Kellinghaus
Journal:  J Neurol       Date:  2009-05-15       Impact factor: 4.849

9.  A clinical, radiological and outcome study of status epilepticus from India.

Authors:  J Kalita; P P Nair; Usha Kant Misra
Journal:  J Neurol       Date:  2010-02       Impact factor: 4.849

Review 10.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.